CNS demyelinating disease following inactivated or viral vector SARS-CoV-2 vaccines: A case series

Narges Ebrahimi1, Mahsa Mazdak2, Vahid Shaygannejad1

  • 1Isfahan Neurosciences Research Center, Isfahan University of Medical Sciences, Isfahan, Iran; Department of Neurology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.

Vaccine
|January 12, 2023
PubMed
Abstract

Related Concept Videos